Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Mahkam Zanganeh

CEO at Summit Therapeutics Inc. (SMMT)

Purchase track record

Market-like. Based on 3 purchases with a full 90 days of price history.

52
Avg. 90-day return+3.2%
vs. S&P 500+1.2%
Beat the market33%
Paper profit on buys+$17.3M
Total bought / sold$51.9M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jun 12SEC SMMTSummit Therapeutics Inc. Buy 3,810,000573,883,879 held (+1%) $13.12 $50.0M +34.1%
Jun 4SEC SMMTSummit Therapeutics Inc. Buy 100,00025,824,474 held (+0%) $14.60 $1.5M +20.5%
Oct 23SEC SMMTSummit Therapeutics Inc. Buy 26,68076,680 held (+53%) $18.74 $500K -6.1%
  • Buy

    CEO Mahkam Zanganeh bought $50.0M of SMMT at $13.12 — largest purchase by this insider in our records.

  • Buy

    CEO Mahkam Zanganeh bought $1.5M of SMMT at $14.60 — largest purchase by this insider in our records.

  • Buy

    CEO Mahkam Zanganeh bought $500K of SMMT at $18.74 — first open-market purchase in our records; raises the stake by 53%.